Showing results (21-30 of 36) with videos related to

Sort By:
Pageof 4
Antimicrobial Agents and Chemotherapy|September 25, 2016
Multidrug-Resistant Pseudomonas aeruginosa Infection in a Child with Cystic FibrosisJocelyn Y Ang, Nahed Abdel-Haq, Frank Zhu, et al.
Frontiers in Pediatrics|August 26, 2021
Acute Kidney Injury in Pediatric Acute SARS-CoV-2 Infection and Multisystem Inflammatory Syndrome in Children (MIS-C): Is There a Difference?Manpreet K Grewal, Melissa J Gregory, Amrish Jain, et al.
American Journal of Perinatology|January 8, 2020
Ceftolozane/Tazobactam in Neonates and Young Infants: The Challenges of Collecting Pharmacokinetics and Safety Data in This Vulnerable Patient PopulationJocelyn Y Ang, Antonio Arrieta, John S Bradley, et al.
Pediatrics|November 14, 2012
A randomized placebo-controlled trial of massage therapy on the immune system of preterm infantsJocelyn Y Ang, Jorge L Lua, Ambika Mathur, et al.
Pediatric Pulmonology|May 19, 2020
Plasma pharmacokinetics of ceftolozane/tazobactam in pediatric patients with cystic fibrosisAntonio C Arrieta, Jocelyn Y Ang, Zufei Zhang, et al.
The Pediatric Infectious Disease Journal|August 29, 2018
Pharmacokinetics and Safety of Single Intravenous Doses of Ceftolozane/Tazobactam in Children With Proven or Suspected Gram-Negative InfectionJohn S Bradley, Jocelyn Y Ang, Antonio C Arrieta, et al.
Global Pediatric Health|June 9, 2021
COVID-19 among Minority Children in Detroit, Michigan during the Early National Surge of the PandemicJocelyn Y Ang, Nirupama Kannikeswaran, Katherine Parker, et al.
European Journal of Pediatrics|January 16, 2021
SARS-CoV-2-associated multisystem inflammatory syndrome in children: clinical manifestations and the role of infliximab treatmentNahed Abdel-Haq, Basim I Asmar, Maria P Deza Leon, et al.
The Pediatric Infectious Disease Journal|March 12, 2021
Pharmacokinetics and Safety of Single-dose Tedizolid Phosphate in Children 2 to <12 Years of AgeAntonio C Arrieta, Jocelyn Y Ang, Claudia Espinosa, et al.
Pageof 4